Sort
261,768 grants matching “gene therapy”
NADPH Oxidases as Novel Targets for Cancer Therapy
$1,024,528James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Retroviral genetic modification of PBLs to optimize expansion for cell therapy
$1,024,494Nicholas Klemen · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The MYC Transcription Factor Network and the Path to Cancer
$1,024,317Robert Neil Eisenman · Fred Hutchinson Cancer Research Center · R35 · FY2019 · CA
Virological Measurements of Cryptic Replication
$1,024,059Mario Stevenson · University Of Minnesota · P01 · FY2009 · AI
SBIR Phase II: High-Throughput Specific Cell Loading by Optoinjection
$1,024,000Glenn Sasaki · Cyntellect, Inc · · FY2003 · TIP
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$1,023,811Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2022 · HL
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke
$1,023,777Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2010 · CA
Inhibition of Malaria Chloroquine Resistance Transporters
$1,023,775M.g. Finn · Scripps Research Institute, The · R56 · FY2010 · AI
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$1,023,737Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
$1,023,733Jin Wang · Baylor College Of Medicine · U01 · FY2023 · AG
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$1,023,709Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$1,023,709Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,023,668Kuan Wang · National Institute Of Mental Health · ZIA · FY2009 · MH
Immunotherapy of low grade lymphoid malignancies
$1,023,663Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Development of Novel Approaches to Optimize CAR T-cell Therapies for B-cell Malignancies
$1,023,609Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIV
$1,023,588Michael Jay Corley · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · MH
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
$1,023,555James D Crapo · Biomimetix Jv, Llc · R44 · FY2016 · CA
Studies of the Natural History of Sickle Cell Disease
$1,023,525Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Program Project Grant
$1,023,474Thomas Jefferson University · P01 · FY2005 · AR
Molecular Biology Of Outer Retina-specific Proteins
$1,023,337Thomas Redmond · National Eye Institute · ZIA · FY2016 · EY
GLIOMAS--BIOLOGIC, MOLECULAR AND GENETIC STUDIES
$1,023,265University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
First-in-class ETS inhibitor TK216: Translational Biology and Oral Dosage Form Development
$1,023,231Rajesh Krishnan · Oncternal Therapeutics, Inc. · R44 · FY2022 · CA
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$1,023,118Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2023 · HL
The Northwestern University Cancer Health Equity Research SPORE (NU-CHERS)
$1,023,100Melissa A. Simon · Northwestern University At Chicago · P20 · FY2021 · CA
Systems Biology Approaches to Viral Pathogenesis and Immunity
$1,023,092Michael G Katze · Oregon Health & Science University · U54 · FY2010 · AI